Stocks · Health care · Pharmaceutical Preparations

BridgeBio Pharma, Inc.

BBIO Clue Score39

United States Fiscal year ends December CIK 0001743881 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

By person

19 insiders · 154 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Neil Kumar

Chief Executive Officer

—

$57.15M (114) scheduled

−$57.15M

5,563,146

2.85%

$405.28M

−24.9%

Jennifer E. Cook

Director

—

$21.92M (6) scheduled

−$21.92M

8,383

0.0043%

$610.70K

+17.2%

Andrew Lo

Director

—

$6.32M (4)

−$6.32M

68,662

0.0351%

$5.00M

−72.9%

Andrea Ellis

Director

—

$5.65M (2) scheduled

−$5.65M

22,579

0.0116%

$1.64M

+88.2%

Hannah Valantine

Director

—

$4.37M (6) scheduled

−$4.37M

9,657

0.0049%

$703.51K

+61.5%

Ronald J Daniels

Director

—

$3.89M (1) scheduled

−$3.89M

20,981

0.0107%

$1.53M

+101.7%

Thomas Trimarchi

President and CFO

—

$3.03M (6) scheduled

−$3.03M

336,529

0.1721%

$24.52M

−15.0%

Randal W. Scott

Director

—

$2.09M (9) scheduled

−$2.09M

11,589

0.0059%

$844.26K

+131.8%

Maricel Apuli

Chief Accounting Officer

—

$767.40K (6) scheduled

−$767.40K

120,687

0.0617%

$8.79M

−3.8%

Viking Global Investors LP entity

10% owner

—

—

—

18,555,375

9.49%

$1.35B

−26.1%

KKR Genetic Disorder L.P.

10% owner

—

—

—

13,260,971

6.78%

$966.06M

−47.5%

Charles J Homcy

Director

—

—

—

919,876

0.4706%

$67.01M

−25.2%

Frank McCormick

Director

—

—

—

690,558

0.3532%

$50.31M

−32.5%

Ali J. Satvat

Director

—

—

—

169,983

0.0870%

$12.38M

—

Brian C Stephenson

CFO and Treasurer

—

—

—

102,464

0.0524%

$7.46M

+20.1%

Fred Hassan

Director

—

—

—

29,879

0.0153%

$2.18M

+54.8%

James C Momtazee

Director

—

—

—

19,070

0.0098%

$1.39M

+124.6%

Douglas A. Dachille

Director

—

—

—

10,579

0.0054%

$770.68K

—

Eric Aguiar

Director

—

—

—

10,579

0.0054%

$770.68K

—